Harnessing lipid nanoparticles for efficient CRISPR delivery.

Biomaterials Science
Jingyue YanYizhou Dong

Abstract

The CRISPR-Cas system has revolutionized the biomedical research field with its simple and flexible genome editing method. In October 2020, Emmanuelle Charpentier and Jennifer A. Doudna were awarded the 2020 Nobel Prize in chemistry in recognition of their outstanding contributions to the discovery of CRISPR-Cas9 genetic scissors, which allow scientists to alter DNA sequences with high precision. Recently, the first phase I clinical trials in cancer patients affirmed the safety and feasibility of ex vivo CRISPR-edited T cells. However, specific and effective CRISPR delivery in vivo remains challenging due to the multiple extracellular and intracellular barriers. Here, we discuss the recent advances in novel lipid nanomaterials for CRISPR delivery and describe relevant examples of potential therapeutics in cancers, genetic disorders, and infectious diseases.

References

Feb 6, 1996·Proceedings of the National Academy of Sciences of the United States of America·Y G KimS Chandrasegaran
Jan 31, 2009·Nature Reviews. Drug Discovery·Kathryn A WhiteheadDaniel G Anderson
Jul 28, 2010·Genetics·Michelle ChristianDaniel F Voytas
May 14, 2011·Chemical Society Reviews·Zhen GuYi Tang
Jul 2, 2011·Nanomedicine·Jesse V JokerstSanjiv S Gambhir
Jun 30, 2012·Science·Martin JinekEmmanuelle Charpentier
Sep 6, 2012·Proceedings of the National Academy of Sciences of the United States of America·Giedrius GasiunasVirginijus Siksnys
Jan 5, 2013·Science·Le CongFeng Zhang
Jan 5, 2013·Science·Prashant MaliGeorge M Church
Feb 7, 2013·ELife·Martin JinekJennifer Doudna
Jul 16, 2014·Nature Reviews. Genetics·Hao YinDaniel G Anderson
Feb 6, 2015·Nature Medicine·David Benjamin Turitz CoxFeng Zhang
May 23, 2015·Molecular Cell·Samuel H Sternberg, Jennifer A Doudna
Jun 30, 2015·Nature Biotechnology·Ayal HendelMatthew H Porteus
Aug 25, 2015·Nature Genetics·Jean-Charles NaultJessica Zucman-Rossi
Oct 4, 2015·Nature·Luciano A Marraffini
Oct 6, 2015·Nature Biotechnology·James E DahlmanSilvana Konermann
Feb 26, 2016·Bioconjugate Chemistry·Bin LiYizhou Dong
Nov 27, 2016·Translational Oncology·Zhixian LiuXiaosheng Wang
Jan 5, 2017·ACS Chemical Biology·Jinghui Song, Chengqi Yi
Jan 11, 2017·Proceedings of the National Academy of Sciences of the United States of America·Colin J McKinlayRobert M Waymouth
Jun 13, 2017·Current Opinion in Microbiology·Eugene V KooninFeng Zhang
Sep 30, 2017·Biomaterials·Wantong SongLeaf Huang
Nov 22, 2017·Trends in Biotechnology·Adrienne C Greene
Dec 7, 2017·ACS Chemical Biology·Katherine S PawelczakJohn J Turchi
Dec 8, 2017·Nucleic Acids Research·Daniel E RyanDouglas J Dellinger
Jan 7, 2018·Trends in Biotechnology·Zachary GlassQiaobing Xu
May 12, 2018·Circulation Research·Michael D ShapiroSergio Fazio
May 17, 2018·Nature Communications·Mazhar Adli
May 29, 2018·Drug Delivery·Christopher A LinoJerilyn A Timlin

❮ Previous
Next ❯

Citations

Nov 24, 2021·Molecular Neurobiology·Lihong GuanJuntang Lin

❮ Previous
Next ❯

Methods Mentioned

BETA
xenograft

Software Mentioned

PAC
MAN

Related Concepts

Related Feeds

CRISPR in Cancer

CRISPR-Cas system enables the editing of genes to create or correct mutations. Given that genome instability and mutation is one of the hallmarks of cancer, the CRISPR-Cas system is being explored to genetically alter and eliminate cancer cells. Here is the latest research.

CRISPR Ribonucleases Deactivation

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on mechanisms that underlie deactivation of CRISPR ribonucleases. Here is the latest research.

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.

© 2021 Meta ULC. All rights reserved